Review
Open access
Oct 2026
A validated clinical calculator of a brain metastasis risk (BrMR) prediction model in stage I-III breast cancer patients.
BACKGROUND Brain metastasis (BM) significantly affects survival and quality of life in patients with breast cancer. A validated tool to predict BM risk at diagnosis of early breast cancer (eBC) could enable targeted surveillance and improve patient selection for clinical trials. METHODS Patients with stage I-III eBC...
A. Raghavendra, N. Kotecki, Kristofer Jennings et al.
· Journal of the National Canc... · 0 citations